Investing.com – Denmark equities were lower at the close on Wednesday, as losses in the Healthcare, Oil & Gas and Consumer Goods sectors propelled shares lower.
At the close in Copenhagen, the OMX Copenhagen 20 fell 1.04% to hit a new 1-month low.
The biggest gainers of the session on the OMX Copenhagen 20 were Novozymes B (COP:NZYMb), which rose 0.13% or 0.4 points to trade at 316.1 at the close. Tryg A/S (COP:TRYG) added 0.07% or 0.1 points to end at 136.5 and Danske Bank A/S (COP:DANSKE) was up 0.05% or 0.1 points to 195.5 in late trade.
Biggest losers included COLOPLAST B (COP:COLOb), which lost 3.88% or 17.3 points to trade at 429.0 in late trade. Genmab (COP:GEN) declined 2.52% or 15.0 points to end at 581.0 and Novo Nordisk B (COP:NOVOb) shed 1.41% or 5.2 points to 364.8.
Declining stocks outnumbered rising ones by 101 to 53 and 6 ended unchanged on the Copenhagen Stock Exchange.
In commodities trading, Crude oil for August delivery was down 1.06% or 0.64 to $59.81 a barrel. Meanwhile, Brent oil for delivery in August fell 0.90% or 0.57 to hit $63.12 a barrel, while the August Gold contract fell 0.42% or 5.00 to trade at $1175.90 a troy ounce.
USD/DKK was down 0.12% to 6.6240, while EUR/DKK fell 0.01% to 7.4577.
The US Dollar Index was down 0.07% at 95.16.